Gross Profit Summary of ChemoMetec A/S

ChemoMetec A/S's latest annual gross profit in 2024 was 367.59 Million DKK , down -7.03% from previous year.
ChemoMetec A/S's latest quarterly gross profit in 2024 FY was 367.59 Million DKK , down -7.03% from previous quarter.
ChemoMetec A/S reported a annual gross profit of 395.39 Million DKK in annual gross profit 2023, up 2.9% from previous year.
ChemoMetec A/S reported a annual gross profit of 384.25 Million DKK in annual gross profit 2022, up 51.67% from previous year.
ChemoMetec A/S reported a quarterly gross profit of 367.59 Million DKK for 2024 FY, down -7.03% from previous quarter.
ChemoMetec A/S reported a quarterly gross profit of 89.81 Million DKK for 2024 Q1, down -24.1% from previous quarter.

Annual Gross Profit Chart of ChemoMetec A/S (2024 - 2004)

Historical Annual Gross Profit of ChemoMetec A/S (2024 - 2004)

Year	Gross Profit	Gross Profit Growth
2024	367.59 Million DKK	-7.03%
2023	395.39 Million DKK	2.9%
2022	384.25 Million DKK	51.67%
2021	253.34 Million DKK	30.64%
2020	193.91 Million DKK	22.25%
2019	158.62 Million DKK	59.46%
2018	99.47 Million DKK	24.04%
2017	80.19 Million DKK	10.92%
2016	72.3 Million DKK	38.44%
2015	52.22 Million DKK	28.51%
2014	40.64 Million DKK	9.94%
2013	36.96 Million DKK	5.73%
2012	34.96 Million DKK	2.87%
2011	33.98 Million DKK	35.65%
2010	25.05 Million DKK	-13.49%
2009	28.96 Million DKK	-29.9%
2008	41.31 Million DKK	122.6%
2007	18.56 Million DKK	41.31%
2006	13.13 Million DKK	14.75%
2005	11.44 Million DKK	32.29%
2004	8.65 Million DKK	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q4	93.98 Million DKK	0.0%
2024 FY	367.59 Million DKK	-7.03%
2024 Q1	89.81 Million DKK	-24.1%
2024 Q2	89.81 Million DKK	0.0%
2024 Q3	93.98 Million DKK	4.64%
2023 FY	395.39 Million DKK	2.9%
2023 Q4	118.34 Million DKK	29.57%
2023 Q3	91.33 Million DKK	-41.0%
2023 Q2	154.8 Million DKK	40.16%
2023 Q1	110.45 Million DKK	-9.26%
2022 FY	384.25 Million DKK	51.67%
2022 Q1	90.84 Million DKK	27.2%
2022 Q2	124.28 Million DKK	36.8%
2022 Q3	101.28 Million DKK	-18.51%
2022 Q4	121.71 Million DKK	20.18%
2021 FY	253.34 Million DKK	30.64%
2021 Q4	71.42 Million DKK	5.51%
2021 Q3	67.69 Million DKK	-0.52%
2021 Q2	68.04 Million DKK	15.36%
2021 Q1	58.98 Million DKK	5.18%
2020 Q2	51.86 Million DKK	10.45%
2020 Q1	46.95 Million DKK	14.86%
2020 Q4	56.07 Million DKK	12.14%
2020 Q3	50 Million DKK	-3.58%
2020 FY	193.91 Million DKK	22.25%
2019 Q4	40.87 Million DKK	-2.18%
2019 Q2	37.52 Million DKK	0.0%
2019 Q1	37.52 Million DKK	42.95%
2019 FY	158.62 Million DKK	59.46%
2019 Q3	41.79 Million DKK	11.38%
2018 Q4	26.24 Million DKK	0.0%
2018 Q2	23.49 Million DKK	0.0%
2018 FY	99.47 Million DKK	24.04%
2018 Q1	23.49 Million DKK	3.98%
2018 Q3	26.24 Million DKK	11.73%
2017 Q3	22.59 Million DKK	29.05%
2017 FY	80.19 Million DKK	10.92%
2017 Q4	22.59 Million DKK	0.0%
2017 Q2	17.5 Million DKK	0.0%
2017 Q1	17.5 Million DKK	-7.56%
2016 FY	72.3 Million DKK	38.44%
2016 Q1	17.21 Million DKK	26.78%
2016 Q2	17.21 Million DKK	0.0%
2016 Q4	18.93 Million DKK	0.0%
2016 Q3	18.93 Million DKK	10.04%
2015 Q4	13.57 Million DKK	0.0%
2015 FY	52.22 Million DKK	28.51%
2015 Q2	12.53 Million DKK	0.0%
2015 Q1	12.53 Million DKK	25.87%
2015 Q3	13.57 Million DKK	8.28%
2014 Q1	10.36 Million DKK	12.24%
2014 Q3	9.96 Million DKK	-3.86%
2014 Q4	9.96 Million DKK	0.0%
2014 FY	40.64 Million DKK	9.94%
2014 Q2	10.36 Million DKK	0.0%
2013 Q2	9.25 Million DKK	0.0%
2013 Q4	9.23 Million DKK	0.0%
2013 Q3	9.23 Million DKK	-0.24%
2013 Q1	9.25 Million DKK	5.85%
2013 FY	36.96 Million DKK	5.73%
2012 Q3	8.74 Million DKK	2.87%
2012 Q4	8.74 Million DKK	0.0%
2012 FY	34.96 Million DKK	2.87%
2012 Q2	8.49 Million DKK	0.0%
2012 Q1	8.49 Million DKK	0.0%
2011 Q1	6.26 Million DKK	0.0%
2011 Q4	8.49 Million DKK	0.0%
2011 Q3	8.49 Million DKK	35.65%
2011 FY	33.98 Million DKK	35.65%
2011 Q2	6.26 Million DKK	0.0%
2010 Q3	6.26 Million DKK	-13.49%
2010 Q2	7.24 Million DKK	0.0%
2010 Q4	6.26 Million DKK	0.0%
2010 Q1	7.24 Million DKK	0.0%
2010 FY	25.05 Million DKK	-13.49%
2009 Q4	7.24 Million DKK	0.0%
2009 Q2	10.32 Million DKK	0.0%
2009 Q1	10.32 Million DKK	0.0%
2009 FY	28.96 Million DKK	-29.9%
2009 Q3	7.24 Million DKK	-29.9%
2008 FY	41.31 Million DKK	122.6%
2008 Q4	10.32 Million DKK	0.0%
2008 Q3	10.32 Million DKK	122.6%
2008 Q1	4.64 Million DKK	0.0%
2008 Q2	4.64 Million DKK	0.0%
2007 Q4	4.64 Million DKK	0.0%
2007 Q3	4.64 Million DKK	41.31%
2007 Q2	3.28 Million DKK	0.0%
2007 FY	18.56 Million DKK	41.31%
2007 Q1	3.28 Million DKK	0.0%
2006 Q4	3.28 Million DKK	0.0%
2006 Q3	3.28 Million DKK	14.75%
2006 FY	13.13 Million DKK	14.75%
2006 Q1	2.86 Million DKK	0.0%
2006 Q2	2.86 Million DKK	0.0%
2005 FY	11.44 Million DKK	32.29%
2005 Q3	2.86 Million DKK	32.29%
2005 Q1	2.16 Million DKK	0.0%
2005 Q2	2.16 Million DKK	0.0%
2005 Q4	2.86 Million DKK	0.0%
2004 Q4	2.16 Million DKK	0.0%
2004 Q3	2.16 Million DKK	0.0%
2004 FY	8.65 Million DKK	0.0%

Peer Gross Profit Comparison of ChemoMetec A/S

Name	Gross Profit	Gross Profit Difference
Ambu A/S	2.96 Billion DKK	87.585%
Demant A/S	16.54 Billion DKK	97.778%
GN Store Nord A/S	8.94 Billion DKK	95.89%
Scandinavian Medical Solutions A/S	34.72 Million DKK	-958.46%
ViroGates A/S	5.8 Million DKK	-6232.386%

Global Stocks Search

ChemoMetec A/S (CHEMM.CO)

Gross Profit Summary of ChemoMetec A/S

Annual Gross Profit Chart of ChemoMetec A/S (2024 - 2004)

Historical Annual Gross Profit of ChemoMetec A/S (2024 - 2004)

Peer Gross Profit Comparison of ChemoMetec A/S